Longboard Pharmaceuticals Inc (LBPH) Stock Price, Quote, News and Overview
NASDAQ:LBPH - Nasdaq - US54300N1037 - Common Stock - Currency: USD
LBPH Quote, Performance and Key Statistics
Longboard Pharmaceuticals Inc
NASDAQ:LBPH (11/29/2024, 7:46:54 PM)
After market: 60.01 +0.03 (+0.05%)59.98
+0.02 (+0.03%)
The current stock price of LBPH is 59.98 USD. In the past month the price increased by 0.44%. In the past year, price increased by 1399.5%.
LBPH Latest News, Press Releases and Analysis
Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt
Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, LBPH, ZUO on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)
Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, LBPH, ZUO on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
LBPH Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 81.23 | 784.20B | ||
| JNJ | JOHNSON & JOHNSON | 15.36 | 369.55B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28.01 | 366.85B | ||
| MRK | MERCK & CO. INC. | 11.88 | 229.54B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.1 | 213.85B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.32 | 210.86B | ||
| PFE | PFIZER INC | 8.32 | 146.61B | ||
| SNY | SANOFI-ADR | 13.51 | 134.13B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.53 | 119.91B | ||
| ZTS | ZOETIS INC | 29.9 | 77.71B | ||
| GSK | GSK PLC-SPON ADR | 8.42 | 71.08B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 30.98 | 42.23B |
Related stock screener links
About LBPH
Company Profile
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company is headquartered in La Jolla, California and currently employs 50 full-time employees. The company went IPO on 2021-03-12. The firm is working to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). The company is focused on developing various product candidates in its pipeline, which includes bexicaserin (LP352) and LP659. The firm plans to advance bexicaserin (LP352), an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with no observed impact on 5-HT2B and 5-HT2A receptor subtypes, into a global Phase 3 program. The company is also evaluating LP659, an oral, centrally acting, sphingosine-1-phosphate (S1P) receptor subtypes 1 and 5 modulator, which is in development for the potential treatment of rare neuroinflammatory conditions. The firm is conducting a Phase 1 single-ascending dose (SAD) clinical trial for LP659 in healthy volunteers.
Company Info
Longboard Pharmaceuticals Inc
4275 Executive Square, Suite 950
La Jolla CALIFORNIA 92121 US
CEO: Kevin R. Lind
Employees: 50
Company Website: https://www.longboardpharma.com/
Phone: 16195929775
LBPH FAQ
What is the stock price of LBPH?
The current stock price of LBPH is 59.98 USD.
What is the symbol for Longboard Pharmaceuticals Inc stock?
The exchange symbol of Longboard Pharmaceuticals Inc is LBPH and it is listed on the Nasdaq exchange.
On which exchange is LBPH stock listed?
LBPH stock is listed on the Nasdaq exchange.
Is LBPH a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for LBPH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of LBPH.
Does LBPH stock pay dividends?
LBPH does not pay a dividend.
What is the Price/Earnings (PE) ratio of LBPH?
LBPH does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.23).
LBPH Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to LBPH. When comparing the yearly performance of all stocks, LBPH is one of the better performing stocks in the market, outperforming 99.74% of all stocks.
LBPH Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to LBPH. While LBPH has a great health rating, there are worries on its profitability.
LBPH Financial Highlights
Over the last trailing twelve months LBPH reported a non-GAAP Earnings per Share(EPS) of -2.23. The EPS increased by 7.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.7% | ||
| ROE | -27.74% | ||
| Debt/Equity | 0 |
LBPH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 75% to LBPH. The Buy consensus is the average rating of analysts ratings from 13 analysts.